MEDILEEN: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDILEEN
Largest movements
- Current investments +€100,000
new in 2025: €100,000
- Cash -€15,823
down €15,823 (-18.4%), from €85,765 to €69,942
mainly Current investments (-€100,000) and Deferred charges and accrued income (-€9,467)
- Deferred charges and accrued income +€9,467
up €9,467 (+54.8%), from €17,268 to €26,734
- Tangible fixed assets +€3,202
up €3,202 (+51.0%), from €6,278 to €9,480
- Profit (loss) carried forward +€102,110
new in 2025: €102,110
- Tax, wage and social debts -€5,677
down €5,677 (-63.2%), from €8,983 to €3,306
- Gross operating margin +€17,729
up €17,729 (+15.1%), from €117,167 to €134,896
- Taxes +€4,323
up €4,323 (+18.0%), from €23,983 to €28,306
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €109,345 | €206,171 | +€96,826 | +88.6% |
| Fixed assets | 21/28 | €6,278 | €9,480 | +€3,202 | +51.0% |
| Tangible fixed assets | 22/27 | €6,278 | €9,480 | +€3,202 | +51.0% |
| Furniture and vehicles | 24 | €6,278 | €9,480 | +€3,202 | +51.0% |
| Current assets | 29/58 | €103,067 | €196,692 | +€93,625 | +90.8% |
| Amounts receivable within one year | 40/41 | €34 | €15 | -€19 | -56.0% |
| Trade receivables | 40 | €34 | €15 | -€19 | -56.0% |
| Current investments | 50/53 | - | €100,000 | +€100,000 | |
| Cash at bank and in hand | 54/58 | €85,765 | €69,942 | -€15,823 | -18.4% |
| Deferred charges and accrued income | 490/1 | €17,268 | €26,734 | +€9,467 | +54.8% |
| Total equity and liabilities | 10/49 | €109,345 | €206,171 | +€96,826 | +88.6% |
| Equity | 10/15 | €98,792 | €200,902 | +€102,110 | +103% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | €94,792 | €94,792 | = | 0.0% |
| Distributable reserves | 133 | €94,792 | €94,792 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €102,110 | +€102,110 | |
| Amounts payable | 17/49 | €10,553 | €5,269 | -€5,284 | -50.1% |
| Amounts payable within one year | 42/48 | €10,491 | €4,082 | -€6,409 | -61.1% |
| Trade debts | 44 | €649 | €776 | +€127 | +19.6% |
| Suppliers | 440/4 | €649 | €776 | +€127 | +19.6% |
| Taxes, remuneration and social security | 45 | €8,983 | €3,306 | -€5,677 | -63.2% |
| Taxes | 450/3 | €8,983 | €3,306 | -€5,677 | -63.2% |
| Other amounts payable | 47/48 | €859 | - | -€859 | |
| Accrued charges and deferred income | 492/3 | €62 | €1,188 | +€1,126 | +1,812% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,222 | €3,429 | +€1,207 | +54.3% |
| Other operating charges | 640/8 | €354 | €868 | +€514 | +145% |
| Gross operating margin | 9900 | €117,167 | €134,896 | +€17,729 | +15.1% |
| Operating profit (loss) | 9901 | €114,592 | €130,599 | +€16,007 | +14.0% |
| Financial income | 75/76B | - | €69 | +€69 | |
| Recurring financial income | 75 | - | €69 | +€69 | |
| Financial charges | 65/66B | €240 | €251 | +€12 | +4.8% |
| Recurring financial charges | 65 | €240 | €251 | +€12 | +4.8% |
| Profit (loss) for the period before taxes | 9903 | €114,352 | €130,416 | +€16,064 | +14.0% |
| Income taxes | 67/77 | €23,983 | €28,306 | +€4,323 | +18.0% |
| Profit (loss) for the period | 9904 | €90,369 | €102,110 | +€11,742 | +13.0% |
| Profit (loss) for the period to be appropriated | 9905 | €90,369 | €102,110 | +€11,742 | +13.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.